Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Herz
Erschienen in: Herz 4/2011

01.06.2011 | Main topic/CME

Cardiac side effects of conventional and particle radiotherapy in cancer patients

verfasst von: PD Dr. A. Wittig, R. Engenhart-Cabillic

Erschienen in: Herz | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

Radiation therapy, which has become an integral part of modern treatment strategies for many types of cancer in recent decades, is associated with the risk of long-term adverse effects. Particularly in the case of patients with a good prognosis as a result of these modern treatment modalities, avoiding therapy-related side effects plays an increasingly important role. Of these side effects, cardiac complications are particularly relevant since they not only adversely affect quality of life but can also be potentially life-threatening. This review summarizes and critically analyzes the available evidence on the impact of ionizing irradiation on the cardiovascular system. The paper presents an overview of the current knowledge on epidemiological evidence, clinical presentation and risk factors of radiation-induced cardiovascular disease. Additionally, mechanisms of development of this type of complication and strategies for screening, treatment, and avoiding cardiac complications are discussed.
Literatur
1.
Adams MJ, Lipsitz SR, Colan SD et al (2004) Cardiovascular status in long-term survivors of Hodgkin’s disease treated with chest radiotherapy. J Clin Oncol 22:3139–3148PubMedCrossRef
2.
Alderson MR, Jackson SM (1971) Long term follow-up of patients with menorrhagia treated by irradiation. Br J Radiol 44:295–298PubMedCrossRef
3.
Ares C, Khan S, MacArtain AM et al (2010) Postoperative proton radiotherapy for localized and locoregional breast cancer: potential for clinically relevant improvements? Int J Radiation Oncology Biol Phys 76:685–697CrossRef
4.
Baker JE, Fish BL, Su J et al (2009) 10 Gy total body irradiation increases risk of coronary sclerosis, degeneration of heart structure and function in a rat model. Int J Radiat Biol 85:1089–1100PubMedCrossRef
5.
Bearzi C, Rota M, Hosoda T et al (2007) Human cardiac stem cells. Proc Natl Acad Sci USA 104:14068–14073PubMedCrossRef
6.
Berrington A, Darby SC, Weiss HA, Doll R (2001) 100 years of observation on British radiologists: mortality from cancer and other causes 1897–1997. Br J Radiol 74:507–519PubMed
7.
Boerma M, Roberto KA, Hauer-Jensen M (2008) Prevention and treatment of functional and structural radiation injury in the rat heart by pentoxifylline and alpha-tocopherol. Int J Radiat Oncol Biol Phys 72:170–177PubMedCrossRef
8.
Brock J, McNair HA, Panakis N et al (2010) The use of the active breathing coordinator throughout radical non-small-cell lung cancer (NSCLC) radiotherapy. Int J Radiat Oncol Biol Phys:Epub ahead of print
9.
Bush DA, Slater JD, Garberoglio C et al (2007) A technique of partial breast irradiation utilizing proton beam radiotherapy: comparison with conformal x-ray Therapy. Cancer J 13:114–118PubMedCrossRef
10.
Cameron EH, Lipshultz SE, Tarbell NJ (1998) Cardiovascular disease in long term survivors of pediatric Hodgkin’s disease. Prog Pediatr Cardiol 8:139–144CrossRef
11.
Cardis E, Gilbert ES, Carpenter L et al (1995) Effects of low doses and low dose rates of external ionizing radiation: cancer mortality among nuclear industry workers in three countries. Radiat Res 142:117–132PubMedCrossRef
12.
Carmel RJ, Kaplan HS (1976) Mantle irradiation in Hodgkin’s disease. An analysis of technique, tumour eradication, and complications. Cancer Res 37:2813–2825
13.
Carr ZA, Land CE, Kleinermann RA et al (2005) Coronary heart disease after radiotherapy for peptic ulcer disease. Int J Radiat Oncol Biol Phys 61:842–850PubMedCrossRef
14.
Carver JR, Shapiro CL, Ng A et al (2007) American Society of Clinical Oncology clinical evidence review on the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol 3991–4008
15.
Caussa L, Kirova YM, Gault N et al (2011) The acute skin and heart toxicity of a concurrent association of trastuzumab and locoregional breast radiotherapy including internal mammary chain: A single-institution study. Eur J Cancer 47:65–73PubMedCrossRef
16.
Clarke M, Collins R, Darby S et al (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366:2087–2106PubMed
17.
Cuzick J, Stewart H, Peto R et al (1987) Overview of randomized trials comparing radical mastectomy without radiotherapy against simple mastectomy with radiotherapy in breast cancer. Cancer Treat Rep 71:7–14PubMed
18.
Cuzick J, Stewart H, Rutqvist L et al (1994) Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 12:447–453PubMed
19.
Darby SC, Doll R, Gill SK, Smith PG (1987) Long term mortality after a single treatment course with X-rays in patients treated for ankylosing spondylitis. Br J Cancer 55:179–190PubMedCrossRef
20.
Darby SC, McGale P, Taylor CW, Peto R (2005) Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol 6:557–565PubMedCrossRef
21.
Darby SC, Reeves G, Key T et al (1994) Mortality in a cohort of women given X-ray therapy for metropathia haemorrhagica. Int J Cancer 56:793–801PubMedCrossRef
22.
Davis FG, Boice J, J.D et al (1987) Cancer mortality after multiple fluoroscopic examinations of the chest. J Natl Cancer Inst 78:645–652PubMed
23.
Earle CC (2007) Cancer survivorship research and guidelines: maybe the cart should be beside the horse. J Clin Oncol 25:3800–3801PubMedCrossRef
24.
Emami B, Lyman J, Brown A et al (1991) Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21:109–122PubMed
25.
Gagliardi G, Constine LS, Moiseenko V et al (2010) Radiation dose–volume effects in the heart. Int J Radiat Oncol Biol Phys 76:S77-S85PubMedCrossRef
26.
Galderisi M, Marra F, Esposito R et al (2007) Cancer therapy and cardiotoxicity: The need of serial Doppler echocardiography. Cardiovascular Ultrasound 5. http://​www.​cardiovascularul​trasound.​com/​content/​5/​1/​4
27.
Geiger S, Lange V, Suhl P et al (2010) Anticancer therapy induced cardiotoxicity: review of the literature. Anti-Cancer Drugs 21:578–590
28.
Giordano SH, Kuo YF, Freeman JL et al (2005) Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst 97:419–424PubMedCrossRef
29.
Giraud P, Yorke E, Jiang S et al (2006) Reduction of organ motion effects in IMRT and conformal 3D radiation delivery by using gating and tracking techniques. Cancer Radiother 10:269–282PubMed
30.
Griem ML, Kleinerman RA, Boice JDJ et al (1994) Cancer following radiotherapy for peptic ulcer. J Natl Cancer Inst 86:842–949PubMedCrossRef
31.
Gyenes G, Fornander TJ, Carlens P, Rutqvist LE (1994) Morbidity of ischemic heart disease in early breast cancer 15–20 years after adjuvant radiotherapy. Int J Radiat Oncol Biol Phys 28:1235–1241PubMedCrossRef
32.
Hancock SL, Tucker MA, Hoppe RT (1993) Factors affecting late mortality from heart disease after treatment of Hodgkin’s disease. JAMA 270:1949–1955PubMedCrossRef
33.
Hauptmann M, Mohan AK, Doody MM et al (2003) Mortality from diseases of the circulatory system in radiologic technologists in the United States. Am J Epidemiol 157:239–248PubMedCrossRef
34.
Hayashi T, Morishita Y, Kubo Y et al (2005) Long-term effects of radiation dose on inflammatory markers in atomic bomb survivors. Am J Med 118:83–86PubMedCrossRef
35.
Heidenreich PA, Hancock SL, Lee BK et al (2003) Asymptomatic cardiac disease following mediastinal irradiation. JACC 42:743–749PubMed
36.
Heidenreich PA, Hancock SL, Vagelos RH et al (2005) Diastolic dysfunction after mediastinal irradiation. Am Heart J 150:977–982PubMedCrossRef
37.
Hendry JH, Akahoshi M, Wang LS et al (2008) Radiation-induced cardiovascular injury. Radiat Environ Biophys 47:189–193PubMedCrossRef
38.
Hong RA, Iimura T, Sumida KN, Eager RM (2010) Cardio-Oncology/Onco-Cardiology. Clin Cardiol 33:733–737PubMedCrossRef
39.
Hooning MJ, Botma A, Aleman BM et al (2007) Long-term risk of cardiovascular disease in 10-year survivors of breast cancer. J Natl Cancer Inst 99:365–375PubMedCrossRef
40.
Hugo GD, Weiss E, Badawi A, Orton M (2011) Localization accuracy of the clinical target volume during image-guided radiotherapy of lung cancer. Int J Radiat Oncol Biol Phys: Epub ahead of print
41.
Hull MC, Morris CG, Pepine CJ, Mendenhall NP (2003) Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of Hodgkin lymphoma treated with radiation therapy. JAMA 290:2831–2837PubMedCrossRef
42.
Jurcut R, Wildiers H, Ganame J et al (2008) Detection and monitoring of cardiotoxicity– what does modern cardiology offer? Support Care Cancer 16:437–445PubMedCrossRef
43.
Kälsch H, Wieneke H, Erbel R (2010) Acute myocardial infarction in a patient with chronic myelocytic leukemia during chemotherapy with hydroxyurea. Herz 35:420–422PubMedCrossRef
44.
Karatolios K, Alter P, Maisch B (2009) Differenzierung von malignen und nichtmalignen, inflammatorischen Perikardergüssen mit Biomarkern. Herz 34:624–633PubMedCrossRef
45.
Kodama K, Fujiwara S, Yamada M et al (1996) Profiles of non-cancer diseases in atomic bomb survivors. World Health Stat Q 49:7–16PubMed
46.
Korreman SS, Pedersen AN, Josipović M et al (2006) Cardiac and pulmonary complication probabilities for breast cancer patients after routine end-inspiration gated radiotherapy. Radiother Oncol 80:257–262PubMedCrossRef
47.
Kruse JJCM, Floot BGJ, te Poele JAM et al (2009) Radiation-induced activation of TGF-β signaling pathways in relation to vascular damage in mouse kidneys. Radiat Res 171:188–197PubMedCrossRef
48.
Lee CK, Aeppli D, Nierengarten ME (2000) The need for long-term surveillance for patients treated with curative radiotherapy for Hodgkin’s disease: University of Minnesota experience. Int J Radiat Oncol Biol Phys 48:169–179PubMedCrossRef
49.
Lee CT, Bilton SD, Famiglietti RM et al (2005) Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques? Int J Radiat Oncol Biol Phys 63:362–372PubMedCrossRef
50.
Lee S, Park Y, Zuidema MY et al (2011) Effects of interventions on oxidative stress and inflammation of cardiovascular diseases. World J Cardiol 3:18–24PubMedCrossRef
51.
Lettmaier S, Kreppner S, Lotter M et al (2010) Radiation exposure of the heart, lung and skin by radiation therapy for breast cancer: A dosimetric comparison between partial breast irradiation using multicatheter brachytherapy and whole breast teletherapy. Radiother Oncol [Epub ahead of print]
52.
Lewis CA, Smith PG, Stratton IM et al (1988) Estimated radiation doses to different organs among patients treated for ankylosing spondylitis with a single course of X rays. Br J Radiol 61:212–220PubMedCrossRef
53.
Lohr F, Heggemann F, Papavassiliu T et al (2009) Ist die Kardiotoxizität der Radiotherapie im Rahmen des Brusterhalts überhaupt noch relevant, und könnte sie durch Mehrfelder-IMRT gesenkt werden? Strahlenther Oncol 185:222–230CrossRef
54.
Lomax AJ, Cella L, Weber D et al (2003) Potential role of intensity-modulated photons and protons in the treatment of the breast and regional nodes. Int J Radiat Oncol Biol Phys 55:785–792PubMedCrossRef
55.
Lorchel F, Dumas JL, Noël A et al (2006) Dosimetric consequences of breath-hold respiration in conformal radiotherapy of esophageal cancer. Phys Med 22:119–126PubMedCrossRef
56.
Marks LB, Yu X, Prosnitz RG, Zhou SM et al (2005) The incidence and functional consequences of RT-associated cardiac perfusion defects. Int J Radiat Oncol Biol Phys 63:214–223PubMedCrossRef
57.
Martel MK, Sahijdak WM, Ten Haken RK et al (1998) Fraction size and dose parameters related to the incidence of pericardial effusions. Int J Radiat Oncol Biol Phys 40:155–161PubMedCrossRef
58.
Michalowski AS (1994) On radiation damage to normal tissues and its treatment. II. Anti-inflammatory drugs. Acta Oncol 33:139–157PubMedCrossRef
59.
Ng AK, Constine LS, Deming RL (2005) American College of Radiology Appropriateness Criteria: Follow-up of Hodgkin’s disease. Department of Quality and Safety, ACH, Reston, VA. http://​www.​acr.​org/​SecondaryMainMen​uCategories/​ quality_safety/app_criteria/pdf/ExpertPanelonRadiation OncologyHodgkinsWorkGroup/FollowUpofHodgkins DiseaseDoc2.aspx 2005
60.
Paszat LF, Mackillop WJ, Groome PA et al (1998) Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the surveillance, epidemiology, and end-results cancer registries. J Clin Oncol 16:2625–2631PubMed
61.
Patt DA, Goodwin JS, Kuo Y-F et al (2005) Cardiac Morbidity of Adjuvant Radiotherapy for Breast Cancer. J Clin Oncol 23:7475–7482PubMedCrossRef
62.
Pignol JP, Keller BM, Ravi A (2011) Doses to internal organs for various breast radiation techniques-implications on the risk of secondary cancers and cardiomyopathy. Radiat Oncol 6
63.
PORT Meta-analysis Trialists Group (2005) Postoperative radiotherapy for non-small cell lung cancer. Cochrane Database Syst Rev 2:CD002142
64.
Preston DL, Shimizu Y, Pierce DA et al (2003) Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950–1997. Radiat Res 160:381–407PubMedCrossRef
65.
Quarmby S, Hunter RD, Kumar S (2000) Irradiation induced expression of CD31, ICAM-1 and VCAM-1 in human microvascular endothelial cells. Anticancer Res 20:3375–3381PubMed
66.
Register SP, Zhang X, Mohan R, Chang JY (2010) Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer. Int J Radiation Oncology Biol Phys epub ahead of print:1–8
67.
Rutqvist LE, Lax I, Fornander TJ, Ohansson H (1992) Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer. Int J Radiat Oncol Biol Phys 22:887–896PubMedCrossRef
68.
Scharpfenecker M, Kruse JJCM, Sprong D et al (2009) Ionizing radiation shifts the PAI-1/ID-1 balance and activates notch signaling in endothelial cells. Int J Radiat Oncol Biol Phys 73:506–513PubMedCrossRef
69.
Schultz-Hector S, Trott KR (2007) Radiation-induced cardiovascular disease: is there epidemiological evidence compatible with the radiobiological data? Int J Radiat Oncol Biol Phys 67:10–18PubMedCrossRef
70.
Slamon DJ, Leyland-Jones B, Shak S et al (2001) Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 344:783–792PubMedCrossRef
71.
Smith PG, Doll R (1976) Late effects of x irradiation in patients treated for metropathia haemorrhagica. Br J Radiol 49:224–232PubMedCrossRef
72.
Stewart FA, Hoving S, Russell NS (2010) Vascular damage as an underlying mechanism of cardiac and cerebral toxicity in irradiated cancer patients. Radiat Res 174:865–869PubMedCrossRef
73.
Stewart JR, Fajardo LF (1971) Dose response in human and experimental radiation-induced heart disease. Application of the nominal standard dose (NSD) concept. Radiology 99:403–408PubMed
74.
Belt-Dusebout AW van den, Wit R de, Gietema JA et al (2007) Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol 25:4370–4378PubMedCrossRef
75.
Pal HJ van der, Dalen EC van, Kremer LC et al (2005) Risk of morbidity and mortality from cardiovascular disease following radiotherapy for childhood cancer: a systematic review. Cancer Treat Rev 31:173–185PubMedCrossRef
76.
Pal HJH van der, Dalen EC van, Kremer LCM et al (2005) Risk of morbidity and mortality from cardiovascular disease following radiotherapy for childhood cancer: A systematic review. Cancer Treat Rev 31:173–185PubMedCrossRef
77.
Van Kleef E, Verheij M, te Poele H et al (2000) In vitro and in vivo expression of endothelial von Willebrand factor and leukocyte accumulation after fractionated irradiation. Radiat Res 154:375–381CrossRef
78.
Luijk P van, Novakova-Jiresova A, Faber H et al (2005) Radiation damage to the heart enhances early radiation-induced lung function loss. Cancer Res 65:6509–6511PubMedCrossRef
79.
Vikström J, Hjelstuen MH, Mjaaland I, Dybvik KI (2011) Cardiac and pulmonary dose reduction for tangentially irradiated breast cancer, utilizing deep inspiration breath-hold with audio-visual guidance, without compromising target coverage. Acta Oncol 50:42–50PubMedCrossRef
80.
Vos J, Aarnoudse MW, Dijk F, Lamberts HB (1983) On the cellular origin and development of atheromatous plaques. A light and electron microscopic study of combined X-ray and hypercholesterolemia- induced atheromatosis in the carotid artery of the rabbit. Virchows Arch B Cell Pathol Incl Mol Pathol 43:1–16PubMedCrossRef
81.
Wei X, Liu HH, Tucker SL et al (2008) Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy. Int J Radiat Oncol Biol Phys 70:707–714PubMedCrossRef
82.
Zagars GK, Ballo MT, Lee AK, Strom SS (2004) Mortality after cure of testicular seminoma. J Clin Oncol 22:640–647PubMedCrossRef
83.
Zhang X, Li Y, Pan X, Xiaoqiang L et al (2010) Intensity-modulated proton therapy reduces the dose to normal tissue compared with intensity-modulated radiation therapy or passive scattering proton therapy and enables individualized radical radiotherapy for extensive stage IIIB non-small-cell lung cancer: a virtual clinical study. Int J Radiat Oncol Biol Phys 77:357–366PubMedCrossRef
Metadaten
Titel
Cardiac side effects of conventional and particle radiotherapy in cancer patients
verfasst von
PD Dr. A. Wittig
R. Engenhart-Cabillic
Publikationsdatum
01.06.2011
Verlag
Urban and Vogel
Erschienen in
Herz / Ausgabe 4/2011
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI
https://doi.org/10.1007/s00059-011-3471-2

Weitere Artikel der Ausgabe 4/2011

Herz 4/2011 Zur Ausgabe

Case study

Sorafenib-associated multivessel coronary artery vasospasm

Main topic/CME

Neuregulin in heart failure

Hot Topics

Blutzucker-Kontrolle und kardiovaskuläres Risiko

Main topic/CME

Treatment of cardiovascular diseases in cancer patients

Case study

Differential diagnosis of pericardial effusion after stem cell transplantation in acute myeloic leukemia

Schwerpunkt/CME

Tumormarker im Perikarderguss bei malignen und nichtmalignen Perikardergüssen

Neu im Fachgebiet Kardiologie

25.04.2024 | Hypotonie | Nachrichten

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 | Hypertonie | Nachrichten

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

24.04.2024 | Adipositas | Nachrichten

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 | ACC 2024 | Nachrichten

Komplette Revaskularisation bei Infarkt: Neue Studie setzt ein Fragezeichen
weitere anzeigen

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen